SCHEMBL17678363

SCHEMBL17678363

CCCCCc1cc(CCCCC)cc(CC(=O)C(=O)O)c1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 2/20 0.73
▸ ALDH1A1 P00352 3/20 0.53
▸ HAO1 Q9UJM8 1/20 0.51
▸ PTGS2 P35354 3/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ HPGD P15428 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ KAT8 Q9H7Z6 2/20 0.45
▸ PPARA Q07869 2/20 0.45
▸ RARB P10826 5/20 0.45
▸ PPARG P37231 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ RARA P10276 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MTOR P42345 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17678364 0.98 GPR84 (0.71) GPR84ALDH1A1HAO1PTGS2CYP3A4
SCHEMBL17683387 0.92 GPR84 (0.63) GPR84ALDH1A1HAO1PTGS2CYP3A4
SCHEMBL17678269 0.85 GPR84 (0.62) GPR84ALDH1A1HAO1PTGS2CYP3A4
SCHEMBL16050416 0.85 GPR84 (0.72) GPR84ALDH1A1PTGS2CYP3A4HPGD
SCHEMBL28049655 0.83 GPR84 (0.70) GPR84ALDH1A1PTGS2CYP3A4HPGD
SCHEMBL16050407 0.83 ALDH1A1 (0.70) GPR84ALDH1A1PTGS2CYP3A4HPGD
SCHEMBL22040784 0.83 ALDH1A1 (0.70) GPR84ALDH1A1PTGS2CYP3A4HPGD
SCHEMBL16050455 0.83 GPR84 (1.00) GPR84ALDH1A1PTGS2CYP3A4HPGD
SCHEMBL17678367 0.83 GPR84 (0.51) GPR84ALDH1A1HAO1PTGS2CYP3A4
SCHEMBL17678267 0.82 GPR84 (0.50) GPR84ALDH1A1HAO1CYP3A4KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170209399-A1 Substituted Aromatic Compounds and Pharmaceutical Compositions For The Prevention And Treatment Of Diabetes PROMETIC PHARMA SMT LIMITED (GB) 2017-07-27 — — US disclosed
US-20170209399-A1 Substituted Aromatic Compounds and Pharmaceutical Compositions For The Prevention And Treatment Of Diabetes PROMETIC PHARMA SMT LIMITED (GB) 2017-07-27 — — US disclosed
WO-2016054726-A1 SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES PROMETIC BIOSCIENCES INC. (CA) 2016-04-14 — — WO disclosed
WO-2016054728-A1 SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS PROMETIC BIOSCIENCES INC. (CA) 2016-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209399-A1 Substituted Aromatic Compounds and Pharmaceutical Compositions For The Prevention And Treatment Of Diabetes GPR119, LIPC, INSR GPR84 1382/4885ALDH1A1 1302/4885HAO1 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback